Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Multicentre Study, Evaluating the Safety, Tolerability, Efficacy, Compliance and Acceptability of Alkalising Treatments at Long-term in Patients With Cystinuria

NCT04137978 is registered in ClinicalTrials.gov with Advicenne Pharma as lead sponsor.

NCT NCT04137978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04137978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Multicentre Study, Evaluating the Safety, Tolerability, Efficacy, Compliance and Acceptability of Alkalising Treatments at Long-term in Patients With Cystinuria
Lead sponsor
Advicenne Pharma
Phase
Phase 2/3
Overall status
Withdrawn
Start date
May 1, 2024
Completion date
August 31, 2025
Enrollment
0 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cystinuria